261 related articles for article (PubMed ID: 26318304)
21. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
Tan HY; Zheng YB; Liu J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
[TBL] [Abstract][Full Text] [Related]
22. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
Wang DS; Zhong B; Zhang MS; Gao Y
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
[TBL] [Abstract][Full Text] [Related]
24. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
Xu L; Li M; Wang M; Yan D; Feng G; An G
BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
[TBL] [Abstract][Full Text] [Related]
25. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
26. Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma.
Rafiee R; Razmara E; Motavaf M; Mossahebi-Mohammadi M; Khajehsharifi S; Rouhollah F; Babashah S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S383-S390. PubMed ID: 36510992
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644
[TBL] [Abstract][Full Text] [Related]
28. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
Hao JP; Ma A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
[TBL] [Abstract][Full Text] [Related]
29. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer.
Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035
[TBL] [Abstract][Full Text] [Related]
30. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
31. Combined serum miR-29c and miR-149 expression analysis as diagnostic genetic markers for colorectal cancer.
Abdul-Maksoud RS; Elsayed RS; Elsayed WSH; Sediq AM; Rashad NM; Shaker SE; Ahmed SM
Biotechnol Appl Biochem; 2021 Aug; 68(4):732-743. PubMed ID: 32678466
[TBL] [Abstract][Full Text] [Related]
32. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
34. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Serum MicroRNA-21 Gene Expression for Diagnosis and Prognosis of Colorectal Cancer.
Ghareib AF; Mohamed RH; Abd El-Fatah AR; Saadawy SF
J Gastrointest Cancer; 2020 Sep; 51(3):818-823. PubMed ID: 31482406
[TBL] [Abstract][Full Text] [Related]
36. Rare circulating microRNAs as biomarkers of colorectal neoplasia.
Adams SV; Newcomb PA; Burnett-Hartman AN; Wurscher MA; Mandelson M; Upton MP; Zhu LC; Potter JD; Makar KW
PLoS One; 2014; 9(10):e108668. PubMed ID: 25286412
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic value of miR-92a, -143, and -145 expression levels in patients with colorectal adenocarcinoma from Romania.
Brînzan C; Aşchie M; Cozaru G; Dumitru E; Mitroi A
Medicine (Baltimore); 2020 Aug; 99(35):e21895. PubMed ID: 32871920
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer.
Li G; Wang Q; Li Z; Shen Y
Rev Esp Enferm Dig; 2020 Nov; 112(11):832-837. PubMed ID: 33054296
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
[TBL] [Abstract][Full Text] [Related]
40. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
